시장보고서
상품코드
1182900

세계의 CADD(Computer Aided Drug Discovery) 시장(2022-2028년) : COVID-19의 영향 분석, 프로세스별, 종류별, 의약품 종류별, 최종사용자별, 지역별 - 업계 분석, 시장 규모, 시장 점유율, 예측

Computer Aided Drug Discovery Market with COVID-19 Impact Analysis, By Process, By Type, By Drug Type, by End-User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 CADD(Computer Aided Drug Discovery) 시장 규모는 2021년에 30억 5,660만 달러에 달하고, 2022-2028년 예측기간 중 12.8%의 CAGR로 확대될 것으로 예상됩니다.

세계의 CADD(Computer Aided Drug Discovery) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인·억제요인 분석, 시장 기회, COVID-19의 영향, 부문별 시장 분석, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공하고 있습니다.

목차

제1장 CADD(Computer Aided Drug Discovery) 시장 : 개요

제2장 주요 요약

  • 시장 내역
    • 프로세스별
    • 종류별
    • 의약품 종류별
    • 최종사용자별
    • 지역별
  • 경쟁 분석

제3장 CADD(Computer Aided Drug Discovery) 시장 : 동향

  • 시장 성장 촉진요인
    • 시장 성장 촉진요인의 영향 분석
  • 시장 성장 억제요인
    • 시장 성장 억제요인의 영향 분석
  • 시장 기회
  • 시장 향후 동향

제4장 CADD(Computer Aided Drug Discovery) : 시장 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 CADD(Computer Aided Drug Discovery) 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 CADD(Computer Aided Drug Discovery) 시장 : 상황

  • 시장 점유율 분석(2021년)
  • 주요 제조업체별 내역 데이터
    • 확립된 기업 분석
    • 신흥 기업 분석

제7장 CADD(Computer Aided Drug Discovery) 시장 : 프로세스별

  • 개요

제8장 CADD(Computer Aided Drug Discovery) 시장 : 종류별

  • 개요

제9장 CADD(Computer Aided Drug Discovery) 시장 : 의약품 종류별

  • 개요

제10장 CADD(Computer Aided Drug Discovery) 시장 : 최종사용자별

  • 개요

제11장 CADD(Computer Aided Drug Discovery) 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제12장 CADD(Computer Aided Drug Discovery) 업계 : 주요 벤더 분석

  • 경쟁 대시보드
  • 기업 개요
    • Aragen Life Sciences Pvt. Ltd.
    • Bioduro-Sundia
    • Schrodinger, Inc.
    • Aris Pharmaceuticals
    • Bayer AG
    • AstraZeneca
    • Charles River Laboratories
    • Albany Molecular Research
    • BOCSCI Inc
    • Open Eye Scientific Software Inc.

제13장 애널리스트의 종합적 전망

제14장 부록

KSM 23.01.25

REPORT HIGHLIGHT

Computer Aided Drug Discovery Market size was valued at USD 3,056.6 Million in 2021, expanding at a CAGR of 12.8% from 2022 to 2028.

Computer-aided drug discovery (CADD) is an effective computational tool used in drug development for the optimization of potential therapeutic compounds. Additionally, it also includes molecular design, molecular modeling, rational drug design, and computational chemistry. CADD has been used to improve the quality to accelerate the process of identified leads. Moreover, CADD techniques are well-linked and become an integral part of the academic sector and pharmaceutical sectors. Furthermore, it is time-saving, quick, and affordable. Due to such benefits, demand for computer-aided drug discovery is expected to increase during the forecast period.

Market Dynamics

The increasing usage of machine learning and artificial intelligence for drug development in healthcare sectors major factors are projected to increase the computer-aided drug discovery market demand. Additionally, the rising development of precious pharmaceutical research and increased chronic and undiagnosed disease is helping to increase the demand for drug development which is further expected to stimulate the CADD market growth. However, a shortage of skilled technicians to operate computer-aided drug discovery may hamper the market growth during the forecast period.

Moreover, CADD is the latest technique in which analysts and researcher monitor, develop, analyze, design, and study the 3D structure of target disease molecules and a combination of software using a complement biomolecule ligand. In addition, this method is popular among researchers due to its speed up drug discovery and research. The major factors to foster the market demand of the computer-aided drug discovery market. The COVID-19 pandemic had a devastating impact on several industries as the CADD market experienced momentous growth. To restrict the coronavirus disease spread CADD market has seen a high rate of growth due to increasing R&D activities among researchers, biotechnological, scientists, and biopharmaceutical companies. Across the world, the increasing spread of coronavirus has motivated scientists to discover an effective treatment or a drug against this deadly virus.

Segmentation Analysis:

The Computer-Aided Drug Discovery Market is segmented on the basis of process, type, drug type, end-user, and by region.

The market is divided into five categories based on the process: target selection, target validation, candidate validation, hit-to-lead identification, and lead optimization. The hit-to-led identification segment is expected to possess the largest market share. Hit-to-led identification helps to contribute to CADD to identify hit compounds.

The market is divided into two categories based on type: chemistry service, and biology service. The chemistry service segment is expected to hold the largest market share during the forecast period. In various early drug development phases, the worldwide applications of chemistry deliver robust candidates.

The market is divided into eight categories based on drug type: small molecule drugs, biological drugs, drug discovery services market by therapeutic area, oncology, infectious and immune system disease, neurology, digestive system disease, cardiovascular disease, and others. The oncology segment is expected to dominate the market. It is a medicinal branch that deals with the prevention, treatment, and diagnosis of cancer. Cancer treatment is one of the major concerns globally due to resistance to medication. Based on this cancer drug demand is increasing that further helping the oncology segment grow.

The market is divided into two categories based on end-user: pharmaceuticals and biotechnology companies, academic institutes, and others. For identifying chemical compounds different types of approaches have been applied that need to be marked and developed. In addition, in pharmaceutical companies, the adoption of computer-aided drug discovery is estimated to grow the pharmaceutical segment.

Competitive Landscape:

The CADD market is growing rapidly due to the increasing combination of different technologies that increase research activities and provide results accurately in a lesser time. The latest technologies like machine learning and artificial intelligence increase the research programs in the pharmaceutical and biotechnological industries increasing the CADD market growth. Additionally, to discover new drugs for various chronic diseases many manufacturing companies have started investing a huge amount that will further help in CADD market growth.

For instance, in December 2021, Curia launched a Comprehensive messenger RNA (mRNA) drug substance. This includes process development, discovery, and mRNA drug substance production through lipid nanoparticle (LNP) formulation and development for full-scale sterile fill-finish services and large-scale lipid manufacturing.

Key features of the study:

  • This proposed research study on computer aided drug discovery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for computer aided drug discovery market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the computer aided drug discovery market
  • Impact of COVID-19 on computer aided drug discovery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on computer aided drug discovery market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the computer aided drug discovery market, we have also included competitive landscape and key innovator analysis for the computer aided drug discovery market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the computer aided drug discovery market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global computer aided drug discovery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

COMPUTER AIDED DRUG DISCOVERY MARKET KEY PLAYERS

  • Aragen Life Sciences Pvt. Ltd.
  • Bioduro-Sundia
  • Schrodinger, Inc.
  • Aris Pharmaceuticals
  • Bayer AG
  • AstraZeneca
  • Charles River Laboratories
  • Albany Molecular Research
  • BOCSCI Inc
  • OpenEye Scientific Software Inc.

COMPUTER AIDED DRUG DISCOVERY MARKET, BY PROCESS

  • Target Selection
  • Target Validation
  • Candidate Validation
  • Hit-to-Lead Identification
  • Lead Optimization

COMPUTER AIDED DRUG DISCOVERY MARKET, BY TYPE

  • Chemistry Service
  • Biology Service

COMPUTER AIDED DRUG DISCOVERY MARKET, BY DRUG TYPE

  • Small Molecule Drugs
  • Biological Drugs,
  • Drug Discovery Services Market by Therapeutic Area
  • Oncology
  • Infectious and Immune System Disease
  • Neurology
  • Digestive System Disease
  • Cardiovascular Disease
  • Others

COMPUTER AIDED DRUG DISCOVERY MARKET, BY END-USER

  • Pharmaceuticals and Biotechnology Companies
  • Academic Institute
  • Others

COMPUTER AIDED DRUG DISCOVERY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

TABLE OF CONTENT

1. Computer Aided Drug Discovery Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Computer Aided Drug Discovery Market Snippet by Process
    • 2.1.2. Computer Aided Drug Discovery Market Snippet by Type
    • 2.1.3. Computer Aided Drug Discovery Market Snippet by Drug Type
    • 2.1.4. Computer Aided Drug Discovery Market Snippet by End-User
    • 2.1.5. Computer Aided Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. Computer Aided Drug Discovery Market Trends

  • 3.1. Computer Aided Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Computer Aided Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Computer Aided Drug Discovery Market Opportunities
  • 3.4. Computer Aided Drug Discovery Market Future Trends

4. Computer Aided Drug Discovery Market Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Computer Aided Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Computer Aided Drug Discovery Market Landscape

  • 6.1. Computer Aided Drug Discovery Market Share Analysis, 2021
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Computer Aided Drug Discovery Market - By Process

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Process, 2021&2028 (%)
    • 7.1.2. Target Selection
    • 7.1.3. Target Validation
    • 7.1.4. Candidate Validation
    • 7.1.5. Hit-to-Lead Identification
    • 7.1.6. Lead Optimization

8. Computer Aided Drug Discovery Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2021&2028 (%)
    • 8.1.2. Chemistry Service
    • 8.1.3. Biology Service

9. Computer Aided Drug Discovery Market - By Drug Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Drug Type, 2021&2028 (%)
    • 9.1.2. Small Molecule Drugs
    • 9.1.3. Biological Drugs,
    • 9.1.4. Drug Discovery Services Market by Therapeutic Area
    • 9.1.5. Oncology
    • 9.1.6. Infectious and Immune System Disease
    • 9.1.7. Neurology
    • 9.1.8. Digestive System Disease
    • 9.1.9. Cardiovascular Disease
    • 9.1.10. Others

10. Computer Aided Drug Discovery Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2021&2028 (%)
    • 10.1.2. Pharmaceuticals and Biotechnology Companies
    • 10.1.3. Academic Institute
    • 10.1.4. Others

11. Computer Aided Drug Discovery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2021&2028 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Computer Aided Drug Discovery Market Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User Type, 2017 - 2028 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Computer Aided Drug Discovery Market Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Photoacoustic ImagingKey Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Computer Aided Drug Discovery Market Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Computer Aided Drug Discovery Market Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2017 - 2028 (US$ Million)

12. Key Vendor Analysis Computer Aided Drug Discovery Market Imaging Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Aragen Life Sciences Pvt. Ltd.
    • 12.2.2. Bioduro-Sundia
    • 12.2.3. Schrodinger, Inc.
    • 12.2.4. Aris Pharmaceuticals
    • 12.2.5. Bayer AG
    • 12.2.6. AstraZeneca
    • 12.2.7. Charles River Laboratories
    • 12.2.8. Albany Molecular Research
    • 12.2.9. BOCSCI Inc
    • 12.2.10. Open Eye Scientific Software Inc.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제